List view / Grid view
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the EC has granted marketing authorisation for Dupixent for use in adults with moderate-to-severe atopic dermatitis...
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer...
Results from a Phase 3 efficacy study in India of the rotavirus vaccine Rotasil showed the vaccine to be safe, against severe rotavirus gastroenteritis...
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
TLR agonists injected directly into a tumour suppresses tumour growth throughout the whole body...
A new treatment for osteoporosis provides major improvements in bone density and fractures than the current standard treatment...
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception...
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
General study identifies targetable pathway that induces immunosuppressive environment in colorectal cancer...
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
Dr Paul Royall, Senior Lecturer in Pharmaceutics at King’s College London, and Programme Director of the MSc in Pharmaceutical Analysis and Quality Control, has joined European Pharmaceutical Review's Editorial Advisory Board.
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
